Clinical Trials Directory

Trials / Sponsors / Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Academic / Other · 7 registered clinical trials.

StatusTrialPhaseStarted
WithdrawnBrentuximab Vedotin in Treating Patients With Steroid-Resistant Acute Graft-Versus-Host Disease
Graft Versus Host Disease
Phase 22012-09-01
WithdrawnFludarabine Phosphate, Rituximab, and Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemi
B-cell Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia
Phase 22009-01-01
CompletedInternet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission
Phase 32008-08-01
CompletedTherapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Stage IV Melan
Recurrent Melanoma, Stage IV Melanoma
Phase 12006-12-01
CompletedReduced Intensity Donor Stem Cell Transplant in Treating Patients With High Risk Acute Lymphocytic Leukemia in
Adult Acute Lymphoblastic Leukemia in Remission, Childhood Acute Lymphoblastic Leukemia in Remission, Recurrent Adult Acute Lymphoblastic Leukemia
Phase 22001-09-01
CompletedVaccine Therapy in Treating Patients With Multiple Myeloma Who Have Undergone Stem Cell Transplantation
Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma
Phase 11996-03-01
WithdrawnLow-Dose Conditioning Followed by Donor Stem Cell Transplant in Treating Patients With Severe Systemic Scleros
Systemic Scleroderma
Phase 2—